199 related articles for article (PubMed ID: 19826631)
1. Identification of continuous human B-cell epitopes in the envelope glycoprotein of dengue virus type 3 (DENV-3).
da Silva AN; Nascimento EJ; Cordeiro MT; Gil LH; Abath FG; Montenegro SM; Marques ET
PLoS One; 2009 Oct; 4(10):e7425. PubMed ID: 19826631
[TBL] [Abstract][Full Text] [Related]
2. [Mapping of the B Cell Neutralizing Epitopes on ED III of Envelope Protein from Dengue Virus].
Lin Y; Wen K; Guo Y; Qiu L; Pan Y; Yu L; Di B; Chen Y
Bing Du Xue Bao; 2015 Nov; 31(6):665-73. PubMed ID: 26951013
[TBL] [Abstract][Full Text] [Related]
3. Natural immunogenic properties of bioinformatically predicted linear B-cell epitopes of dengue envelope and pre-membrane proteins.
Nadugala MN; Jeewandara C; Jadi RS; Malavige GN; de Silva AM; Premaratne PH; Goonasekara CL
BMC Immunol; 2021 Nov; 22(1):71. PubMed ID: 34732126
[TBL] [Abstract][Full Text] [Related]
4. Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine.
Ramanathan B; Poh CL; Kirk K; McBride WJ; Aaskov J; Grollo L
PLoS One; 2016; 11(5):e0155900. PubMed ID: 27223692
[TBL] [Abstract][Full Text] [Related]
5. Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses.
Li S; Peng L; Zhao W; Zhong H; Zhang F; Yan Z; Cao H
Vaccine; 2011 May; 29(20):3695-702. PubMed ID: 21419774
[TBL] [Abstract][Full Text] [Related]
6. Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement.
Hughes HR; Crill WD; Chang GJ
Virol J; 2012 Jun; 9():115. PubMed ID: 22709350
[TBL] [Abstract][Full Text] [Related]
7. Development of Global Consensus of Dengue Virus Envelope Glycoprotein for Epitopes Based Vaccine Design.
Hussain M; Idrees M; Afzal S
Curr Comput Aided Drug Des; 2015; 11(1):84-97. PubMed ID: 26022067
[TBL] [Abstract][Full Text] [Related]
8. Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.
Hertz T; Beatty PR; MacMillen Z; Killingbeck SS; Wang C; Harris E
J Immunol; 2017 May; 198(10):4025-4035. PubMed ID: 28381638
[TBL] [Abstract][Full Text] [Related]
9. T Cell Responses Induced by DNA Vaccines Based on the DENV2 E and NS1 Proteins in Mice: Importance in Protection and Immunodominant Epitope Identification.
Pinto PBA; Assis ML; Vallochi AL; Pacheco AR; Lima LM; Quaresma KRL; Pereira BAS; Costa SM; Alves AMB
Front Immunol; 2019; 10():1522. PubMed ID: 31333657
[TBL] [Abstract][Full Text] [Related]
10. The Immunodominance Change and Protection of CD4+ T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in Mice.
Chen HW; Hu HM; Wu SH; Chiang CY; Hsiao YJ; Wu CK; Hsieh CH; Chung HH; Chong P; Leng CH; Pan CH
PLoS One; 2015; 10(12):e0145717. PubMed ID: 26714037
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a linearized B-cell epitope on the pr protein of dengue virus.
Song KY; Zhao H; Li SH; Li XF; Deng YQ; Wang HJ; Ye Q; Zhu SY; Jiang ZY; Zhang FC; Qin ED; Qin CF
J Gen Virol; 2013 Jul; 94(Pt 7):1510-1516. PubMed ID: 23559476
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins.
Zidane N; Dussart P; Bremand L; Bedouelle H
BMC Infect Dis; 2013 Jul; 13():302. PubMed ID: 23815496
[TBL] [Abstract][Full Text] [Related]
13. Immunodomination of Serotype-Specific CD4+ T-Cell Epitopes Contributed to the Biased Immune Responses Induced by a Tetravalent Measles-Vectored Dengue Vaccine.
Lin TH; Chen HW; Hsiao YJ; Yan JY; Chiang CY; Chen MY; Hu HM; Wu SH; Pan CH
Front Immunol; 2020; 11():546. PubMed ID: 32300346
[TBL] [Abstract][Full Text] [Related]
14. Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes.
Uno N; Ross TM
J Virol; 2021 Jan; 95(4):. PubMed ID: 33208445
[TBL] [Abstract][Full Text] [Related]
15. Detection of Dengue Virus-Specific IgM and IgG Antibodies through Peptide Sequences of Envelope and NS1 Proteins for Serological Identification.
Nagar PK; Savargaonkar D; Anvikar AR
J Immunol Res; 2020; 2020():1820325. PubMed ID: 32832567
[TBL] [Abstract][Full Text] [Related]
16. Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.
Frei JC; Wirchnianski AS; Govero J; Vergnolle O; Dowd KA; Pierson TC; Kielian M; Girvin ME; Diamond MS; Lai JR
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976679
[TBL] [Abstract][Full Text] [Related]
17. Identification of B-Cell Epitopes with Potential to Serologicaly Discrimnate Dengue from Zika Infections.
Versiani AF; Rocha RP; Mendes TAO; Pereira GC; Coelho Dos Reis JGA; Bartholomeu DC; da Fonseca FG
Viruses; 2019 Nov; 11(11):. PubMed ID: 31752352
[TBL] [Abstract][Full Text] [Related]
18. B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.
Priyamvada L; Cho A; Onlamoon N; Zheng NY; Huang M; Kovalenkov Y; Chokephaibulkit K; Angkasekwinai N; Pattanapanyasat K; Ahmed R; Wilson PC; Wrammert J
J Virol; 2016 Jun; 90(12):5574-85. PubMed ID: 27030262
[TBL] [Abstract][Full Text] [Related]
19. An Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2.
Tang CT; Li PC; Liu IJ; Liao MY; Chiu CY; Chao DY; Wu HC
PLoS Negl Trop Dis; 2015; 9(7):e0003903. PubMed ID: 26135599
[TBL] [Abstract][Full Text] [Related]
20. Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models.
Shukla R; Beesetti H; Brown JA; Ahuja R; Ramasamy V; Shanmugam RK; Poddar A; Batra G; Krammer F; Lim JK; Kale S; Lal AA; Swaminathan S; Khanna N
EBioMedicine; 2020 Oct; 60():102991. PubMed ID: 32949997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
